Stay updated on Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page.

Latest updates to the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page's revision tag was updated to v3.5.4, replacing the previous v3.5.3.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe page’s revision/version label in the footer was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision banner updated from v3.5.0 to v3.5.2; the old v3.5.0 label was removed.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision history updated: a new version v3.5.0 is now listed, replacing the previous v3.4.3.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check111 days agoChange DetectedRevision: v3.4.2 appears to be an administrative update, and the removal of the prior funding-status notice (Revision: v3.4.1) does not affect trial details or patient-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page.